These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 14679273

  • 1. Screening for proteinuria in US adults: a cost-effectiveness analysis.
    Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR.
    JAMA; 2003 Dec 17; 290(23):3101-14. PubMed ID: 14679273
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K, White S, Salkeld G, McDonald S, Craig JC, Chadban S, Cass A.
    Value Health; 2010 Dec 17; 13(2):196-208. PubMed ID: 19878493
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.
    CDC Diabetes Cost-effectiveness Group.
    JAMA; 2002 May 15; 287(19):2542-51. PubMed ID: 12020335
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW.
    Nephrology (Carlton); 2019 Jan 15; 24(1):56-64. PubMed ID: 29206319
    [Abstract] [Full Text] [Related]

  • 7. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.
    Golan L, Birkmeyer JD, Welch HG.
    Ann Intern Med; 1999 Nov 02; 131(9):660-7. PubMed ID: 10577328
    [Abstract] [Full Text] [Related]

  • 8. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.
    Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE, Centers for Disease Control and Prevention CKD Initiative.
    Am J Kidney Dis; 2010 Mar 02; 55(3):463-73. PubMed ID: 20116910
    [Abstract] [Full Text] [Related]

  • 9. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.
    Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.
    Ann Intern Med; 2004 May 04; 140(9):689-99. PubMed ID: 15126252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Visual screening for malignant melanoma: a cost-effectiveness analysis.
    Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, Freedberg KA.
    Arch Dermatol; 2007 Jan 04; 143(1):21-8. PubMed ID: 17224538
    [Abstract] [Full Text] [Related]

  • 13. The cost effectiveness of ACE inhibitors as first-line antihypertensive therapy.
    Nordmann AJ, Krahn M, Logan AG, Naglie G, Detsky AS.
    Pharmacoeconomics; 2003 Jan 04; 21(8):573-85. PubMed ID: 12751915
    [Abstract] [Full Text] [Related]

  • 14. A cost-effectiveness analysis of screening urine dipsticks in well-child care.
    Sekhar DL, Wang L, Hollenbeak CS, Widome MD, Paul IM.
    Pediatrics; 2010 Apr 04; 125(4):660-3. PubMed ID: 20231188
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA.
    Lung Cancer; 2005 May 04; 48(2):171-85. PubMed ID: 15829317
    [Abstract] [Full Text] [Related]

  • 17. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
    Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR.
    JAMA; 2003 Jan 15; 289(3):313-22. PubMed ID: 12525232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB, Wittenborn JS, Lee PP, Wirth KE, Sorensen SW, Hoerger TJ, Saaddine JB.
    Ophthalmology; 2009 May 15; 116(5):823-32. PubMed ID: 19285730
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.